Literature DB >> 22137880

Malignant potential of pleomorphic xanthoastrocytoma.

Tamara M Vu1, Simon V Liubinas, Michael Gonzales, Katharine J Drummond.   

Abstract

Pleomorphic xanthoastrocytoma (PXA) is a low-grade astrocytic tumour that occasionally progresses to a higher grade. We have extensively reviewed the literature on the potential for malignant transformation of PXA. An illustrative case of a PXA transforming to glioblastoma multiforme is presented.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22137880     DOI： 10.1016/j.jocn.2011.07.015

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN： 0967-5868            Impact factor:   1.961


  14 in total

1.  Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up.

Authors:  Cristiane M Ida; Fausto J Rodriguez; Peter C Burger; Alissa A Caron; Sarah M Jenkins; Grant M Spears; Dawn L Aranguren; Daniel H Lachance; Caterina Giannini
Journal:  Brain Pathol       Date:  2014-12-05       Impact factor: 6.508

2.  Impact of WHO 2016 update of brain tumor classification, molecular markers and clinical outcomes in pleomorphic xanthoastrocytoma.

Authors:  Raees Tonse; Tejpal Gupta; Sridhar Epari; Jayant Goda Shastri; Mamta Gurav; Nazia Bano; Rakesh Jalali
Journal:  J Neurooncol       Date:  2017-11-16       Impact factor: 4.130

3.  Anaplastic PXA in adults: case series with clinicopathologic and molecular features.

Authors:  Yao Schmidt; B K Kleinschmidt-DeMasters; Dara L Aisner; Kevin O Lillehei; Denise Damek
Journal:  J Neurooncol       Date:  2012-10-25       Impact factor: 4.130

Review 4.  Aggressive behavior and anaplasia in pleomorphic xanthoastrocytoma: a plea for a revision of the current WHO classification.

Authors:  Nesibe Kahramancetin; Tarik Tihan
Journal:  CNS Oncol       Date:  2013-11

5.  Epithelioid GBMs show a high percentage of BRAF V600E mutation.

Authors:  Bette Kay Kleinschmidt-DeMasters; Dara L Aisner; Diane K Birks; Nicholas K Foreman
Journal:  Am J Surg Pathol       Date:  2013-05       Impact factor: 6.394

6.  Salvage therapy with BRAF inhibitors for recurrent pleomorphic xanthoastrocytoma: a retrospective case series.

Authors:  Marc C Chamberlain
Journal:  J Neurooncol       Date:  2013-06-12       Impact factor: 4.130

7.  A rare clinical presentation: a pleomorphic xanthoastrocytoma presenting with intracerebral haemorrhage and metastasizing vigorously-case report and review of the literature.

Authors:  Gülden Demirci Otluoğlu; M Memet Özek
Journal:  Childs Nerv Syst       Date:  2018-09-04       Impact factor: 1.475

8.  Differences in treatment patterns and overall survival between grade II and anaplastic pleomorphic xanthoastrocytomas.

Authors:  Adrian Rodrigues; Hriday Bhambhvani; Zachary A Medress; Shreya Malhotra; Melanie Hayden-Gephart
Journal:  J Neurooncol       Date:  2021-05-10       Impact factor: 4.130

9.  Atypical pleomorphic neoplasms of the pineal gland: Case report and review of the literature.

Authors:  M Praver; R D'Amico; C Arraez; B E Zacharia; H Varma; J E Goldman; J N Bruce; P Canoll
Journal:  Surg Neurol Int       Date:  2015-07-30

10.  Glioblastoma multiforme versus pleomorphic xanthoastrocytoma with anaplastic features in the pathological diagnosis: a case report.

Authors:  Shoko M Yamada; Hideki Murakami; Yusuke Tomita; Makoto Nakane; Soichiro Shibui; Mikiko Takahashi; Masashi Kawamoto
Journal:  Diagn Pathol       Date:  2016-07-22       Impact factor: 2.644
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.